Eylea（アイリーア）の世界市場レポート 2024年

Eylea（アイリーア）市場規模は近年力強く成長しています。2023年の78億米ドルから2024年には81億9,000万米ドルに、CAGR5.1％で成長します。Eylea（アイリーア）の実績期間に観察された成長は、いくつかの要因に起因しています。糖尿病黄斑浮腫（DME）の流行、Eylea（アイリーア）の臨床的有効性と安全性の実証、他の抗VEGF療法（血管内皮増殖因子阻害薬）との競合、様々な網膜疾患の治療に対する承認、網膜疾患に対する硝子体内注射への治療アプローチの顕著なシフトなどです。これらの要因が、歴史的な期間におけるEylea（アイリーア）の需要と成長に寄与しています。

2023年のEylea（アイリーア）市場で最大の地域は北米でした。アジア太平洋は、予測期間中にEylea（アイリーア）市場で最も急成長する地域となる見込みです。Eylea（アイリーア）市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 Eylea（アイリーア）市場の特徴

第3章 Eylea（アイリーア）市場の動向と戦略

第4章 Eylea（アイリーア）市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界のEylea（アイリーア）市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 Eylea（アイリーア）市場セグメンテーション

• 世界のEylea（アイリーア）市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• プレフィルドシリンジパッケージ
• バイアルパッケージ
• 世界のEylea（アイリーア）市場、疾患別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 滲出性加齢黄斑変性症（AMD）
• 糖尿病性網膜症
• その他の疾患
• 世界のEylea（アイリーア）市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院
• 小売薬局
• その他の用途

第7章 Eylea（アイリーア）市場の地域および国分析

• 世界のEylea（アイリーア）市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のEylea（アイリーア）市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋のEylea（アイリーア）市場

第9章 中国Eylea（アイリーア）市場

第10章 インドEylea（アイリーア）市場

第11章 日本Eylea（アイリーア）ア市場

第12章 オーストラリアEylea（アイリーア）市場

第13章 インドネシアEylea（アイリーア）市場

第14章 韓国Eylea（アイリーア）市場

第15章 西欧のEylea（アイリーア）市場

第16章 英国Eylea（アイリーア）市場

第17章 ドイツEylea（アイリーア）市場

第18章 フランスEylea（アイリーア）市場

第19章 イタリアEylea（アイリーア）ア市場

第20章 スペインEylea（アイリーア）市場

第21章 東欧のEylea（アイリーア）市場

第22章 ロシアのEylea（アイリーア）ア市場

第23章 北米Eylea（アイリーア）市場

第24章 米国Eylea（アイリーア）市場

第25章 カナダEylea（アイリーア）市場

第26章 南米Eylea（アイリーア）市場

第27章 ブラジルEylea（アイリーア）市場

第28章 中東Eylea（アイリーア）市場

第29章 アフリカEylea（アイリーア）市場

第30章 Eylea（アイリーア）市場の競合情勢と企業プロファイル

• Eylea（アイリーア）市場の競合情勢
• Eylea（アイリーア）マーケット企業プロファイル
  • Regeneron Pharmaceuticals Inc.
  • Bayer AG
  • Santen Pharmaceutical Co Ltd
  • Momenta Pharmaceuticals Inc.
  • Novartis AG

第31章 世界のEylea（アイリーア）市場の競合ベンチマーキング

第32章 世界Eylea（アイリーア）市場競争力ダッシュボード

第33章 Eylea（アイリーア）市場における主要な合併と買収

第34章 Eylea（アイリーア）市場の将来展望と可能性分析

第35章 付録

“Eylea Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on eylea market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for eylea? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The eylea market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Prefilled Syringe Package; Vial Package
• 2) By Disorder: Wet Age-Related Macular Degeneration (AMD); Diabetic Retinopathy; Other Disorders
• 3) By Application: Hospitals; Retail Pharmacy; Other Applications
• Companies Mentioned: Regeneron Pharmaceuticals Inc.; Bayer AG; Santen Pharmaceutical Co Ltd; Momenta Pharmaceuticals Inc.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Eylea is a drug administered through eye injections designed to slow vision loss and address certain diseases by inhibiting the leaking and growth of fluid from abnormal blood vessels at the back of the eye. It is primarily used in the treatment of age-related macular degeneration (AMD).

The main packaging formats for Eylea include prefilled syringe packages and vial packages. Prefilled syringe packages are disposable syringes that come pre-loaded with the drug, streamlining the administration process. Eylea is employed in the treatment of conditions such as wet age-related macular degeneration (AMD), diabetic retinopathy, and other disorders. These medications are typically distributed through hospitals, retail pharmacies, and other healthcare applications.

The eylea market research report is one of a series of new reports from The Business Research Company that provides eylea market statistics, including eylea industry global market size, regional shares, competitors with an eylea market share, detailed eylea market segments, market trends and opportunities, and any further data you may need to thrive in the eylea industry. This eylea market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The eylea market size has grown strongly in recent years. It will grow from $7.8 billion in 2023 to $8.19 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth observed in the historic period for Eylea can be attributed to several factors. These include the prevalence of diabetic macular edema (DME), the demonstrated clinical efficacy and safety profile of Eylea, competition with other anti-VEGF therapies (vascular endothelial growth factor inhibitors), approvals for treating various retinal conditions, and a notable shift in the treatment approach towards intravitreal injections for retinal disorders. These factors collectively contributed to the demand and growth of Eylea in the historic period.

The eylea market size is expected to see strong growth in the next few years. It will grow to $10.16 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The anticipated growth in the forecast period for Eylea can be attributed to several factors. These include the emergence of new therapeutic indications, the introduction of biosimilar competition in the market, a rise in awareness and diagnosis of relevant conditions, the importance of real-world evidence and post-market studies, and a growing preference among patients for less frequent injections. Major trends expected in this period include advancements in imaging technologies for more accurate diagnosis and monitoring, the increasing role of telemedicine and remote monitoring in eye care, the implementation of patient assistance programs, continuous advances in drug delivery technologies, innovations in retinal imaging technologies, and the conduct of clinical trials exploring new indications for Eylea. These trends collectively contribute to the evolving landscape of Eylea in the forecast period.

The expansion of the Eylea market is being driven by the increasing prevalence of ocular diseases, which encompasses various eye conditions hindering proper eye function and impacting vision clarity. Eylea, a treatment addressing ocular diseases such as wet age-related macular degeneration (AMD) and glaucoma, works by impeding the protein responsible for the growth of weakened blood vessels and reducing retina swelling caused by vessel blockages. As of October 2022, reports from the BrightFocus Foundation estimated around 80 million global cases of glaucoma, expected to surpass 111 million by 2040. This upsurge in ocular diseases is a key driver for the growing demand for Eylea.

The anticipated growth of the Eylea market is attributed to the rising global geriatric population, generally aged 65 and above. This demographic shift significantly contributes to the increasing prevalence of conditions treated by Eylea, as older individuals are at a higher risk of developing ocular diseases. Statistics from the World Health Organization in October 2022 predicted a considerable rise in the global population aged 60 and above, projecting an increase from 1 billion in 2020 to approximately 1.4 billion by 2022. This trend is expected to continue, with estimates indicating that by 2030, 1 in 6 people globally will be aged 60 or older. Hence, this demographic shift is a major catalyst driving the expansion of the Eylea market.

A prominent trend in the Eylea market involves extensive research and development efforts aimed at innovative solutions. Key players, such as Regeneron Pharmaceuticals, Inc., are committed to pioneering technical advancements in Eylea. In August 2023, Regeneron Pharmaceuticals secured approval from the US FDA for Eylea HD (aflibercept) injection 8 mg. This approval extends Eylea's application to treat patients with wet AMD, diabetic macular edema (DME), and diabetic retinopathy (DR). The treatment regimen involves an initial phase of injections every four weeks for three months across all indications, followed by adjusted intervals of every eight to 16 weeks for wAMD and DME, and every eight to 12 weeks for diabetic retinopathy. This signifies the industry's dedication to evolving treatment strategies and enhancing patient care through continual research and development initiatives.

Major players in the eylea market are strategically focusing on the development of biologic medications, specifically biosimilars akin to aflibercept, to secure a competitive edge within the industry. Aflibercept Biosimilars represent biologically comparable iterations of the reference drug aflibercept, engineered to exhibit no clinically significant disparities and offer a cost-efficient substitute for treating certain eye-related conditions. For instance, in September 2023, Biocon Biologics Ltd., an India-based biopharmaceutical company, secured marketing authorization from the European Commission (EC) for YESAFILI, a biosimilar version of Aflibercept, within the European Union (EU). The EC's endorsement, following a favorable review by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) in July, signifies YESAFILI's compatibility in quality, safety, and efficacy with the reference product Eylea (aflibercept). YESAFILI is specifically designed as an ophthalmological treatment for various eye conditions.

In January 2023, Coherus BioSciences Inc., a US-based biopharmaceutical entity, acquired exclusive commercialization rights to the Eylea Biosimilar Candidate from Klinge Biopharma GmbH for $32.5 million. This acquisition underscores Coherus BioSciences' commitment to expanding treatment options and improving access for both physicians and patients seeking high-quality and affordable alternatives to anti-VEGF therapies across the healthcare spectrum. Klinge Biopharma GmbH, a Germany-based pharmaceutical company, specializes in providing ocular disease drugs such as Eylea Biosimilar. This strategic move allows Coherus BioSciences to fortify its portfolio in offering alternative treatments while expanding its market reach in ocular care.

Major companies operating in the eylea market report are Regeneron Pharmaceuticals Inc., Bayer AG, Santen Pharmaceutical Co Ltd, Momenta Pharmaceuticals Inc., Novartis AG, Mylan NV, Vertex Pharmaceuticals Incorporated, Alvotech Switzerland AG, Sanofi SA, F Hoffmann-La Roche AG, PV Pharma, Alteogen Inc., Viatris Inc., Biocon Biologics Limited, Nexus Lifecare Pvt Ltd, AbbVie Inc., Alcon Inc., Alkem Laboratories Ltd., Intas Pharmaceuticals Ltd., Amgen Inc., Apotex Inc., Aurobindo Pharma Ltd., Lupin Ltd., Biogen Inc., Bristol-Myers Squibb Company, Cipla Ltd, Dr. Reddy's Laboratories Ltd, Merck & Co. Inc., Fresenius Kabi AG, Hikma Pharmaceuticals PLC .

North America was the largest region in the eylea market in 2023. Asia-Pacific is expected to be the fastest-growing region in the eylea market during the forecast period. The regions covered in the eylea market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the eylea market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The eylea market consists of sales of single-dose vials and single-dose prefilled syringes of Eylea. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Eylea Market Characteristics

3. Eylea Market Trends And Strategies

4. Eylea Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Eylea Market Size and Growth

• 5.1. Global Eylea Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Eylea Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Eylea Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Eylea Market Segmentation

• 6.1. Global Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Prefilled Syringe Package
• Vial Package
• 6.2. Global Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Wet Age-Related Macular Degeneration (AMD)
• Diabetic Retinopathy
• Other Disorders
• 6.3. Global Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Retail Pharmacy
• Other Applications

7. Eylea Market Regional And Country Analysis

• 7.1. Global Eylea Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Eylea Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Eylea Market

• 8.1. Asia-Pacific Eylea Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Eylea Market

• 9.1. China Eylea Market Overview
• 9.2. China Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Eylea Market

• 10.1. India Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Eylea Market

• 11.1. Japan Eylea Market Overview
• 11.2. Japan Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Eylea Market

• 12.1. Australia Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Eylea Market

• 13.1. Indonesia Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Eylea Market

• 14.1. South Korea Eylea Market Overview
• 14.2. South Korea Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Eylea Market

• 15.1. Western Europe Eylea Market Overview
• 15.2. Western Europe Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Eylea Market

• 16.1. UK Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Eylea Market

• 17.1. Germany Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Eylea Market

• 18.1. France Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Eylea Market

• 19.1. Italy Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Eylea Market

• 20.1. Spain Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Eylea Market

• 21.1. Eastern Europe Eylea Market Overview
• 21.2. Eastern Europe Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Eylea Market

• 22.1. Russia Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Eylea Market

• 23.1. North America Eylea Market Overview
• 23.2. North America Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Eylea Market

• 24.1. USA Eylea Market Overview
• 24.2. USA Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Eylea Market

• 25.1. Canada Eylea Market Overview
• 25.2. Canada Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Eylea Market

• 26.1. South America Eylea Market Overview
• 26.2. South America Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Eylea Market

• 27.1. Brazil Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Eylea Market

• 28.1. Middle East Eylea Market Overview
• 28.2. Middle East Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Eylea Market

• 29.1. Africa Eylea Market Overview
• 29.2. Africa Eylea Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Eylea Market, Segmentation By Disorder, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Eylea Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Eylea Market Competitive Landscape And Company Profiles

• 30.1. Eylea Market Competitive Landscape
• 30.2. Eylea Market Company Profiles
  • 30.2.1. Regeneron Pharmaceuticals Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Santen Pharmaceutical Co Ltd
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Momenta Pharmaceuticals Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Eylea Market Competitive Benchmarking

32. Global Eylea Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Eylea Market

34. Eylea Market Future Outlook and Potential Analysis

• 34.1 Eylea Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Eylea Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Eylea Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer